By Yue Leng et al.
Source Jamanetwork
Alzheimer disease (AD) and related dementia (ADRD) are devastating diseases that affect over 55 million people worldwide and impose an estimated economic burden of over $800 billion annually.1 This figure is projected to increase as the global population ages, with the prevalence of AD/ADRD expected to triple over the next 30 years.1 To date, there is no cure to stop or reverse disease progression, underscoring the critical need for the development of primary or secondary prevention strategies that target modifiable risk factors to delay or prevent the onset of clinical symptoms.
Read more https://jamanetwork.com/journals/jamaneurology/article-abstract/2814689